Member Info for BodRuncie

I decided to follow the board's example and add a little more this morning.

This share is in a great place right now: board member/fund accumulating frequently at full market price, in a growing sector, a dynamic CEO, and a quiet message board! The herd are not here yet :)

Over the past 12 months, even 6 months, MKA has spent a lot of time under 24p. The board did really well imo to raise funds at that level, I was expecting it to be much lower.

AIM stocks tend to drift when there is a lack of news. Maybe it's because AIM attracts more of the short-term gambler-type mentality? PI exuberance and big RNSs send the share price upwards, but the rest of the time is patience while the share price drifts.

Without any news, and barring any PI exuberance, the share price will continue to drift towards 24p, where there will be strong support, but it could drift lower, and has been lower recently. I would say there is a lot of PI exuberance already in MKA, so we can't expect the herd to arrive yet, without news.

I haven't topped up yet as I feel this could continue to drift lower for the time being. I have a decent (for me) amount of money in MKA already, and still in profit, so I need to temper my greed with a balanced portfolio, but the closer it gets to 24p the itchier my trigger finger will get.

It's not for no reason, it's speculation. You can, and do, get rises like this, catching tailwinds from other hot shares in the same sector.

However, I very much hope there is a damn solid reason for today's 16% rise :)

I find it hard to believe that Mr Scott would let Kestrel keep investing if he wasn't certain of a higher share price in the future.

It's a lot of eggs in this basket for them.

The sales are most likely shares being flipped for a quick profit from the 24p placing price.

This happens in every company with every placing, the share price will drift down to the placing price. 18m shares (12% of the company) were available to trade from yesterday.

There will be stronger support the closer the sp drifts towards 24p, so your 20p guess is unlikely to happen without significant negative news. The markets are shaky at the moment, but that didn't stop MKA rising to 30p over the past week or so.

This was the placing I have been expecting ever since the Polish plant was announced, and I am glad it was at 24p, rather than a much lower figure. I am looking to time a top-up but I will wait for a bit more churn and drift because I think it has a little lower to go.

@Oogle, you said "Shows how little interest there is in buying shares at the moment across the board."

lol, but ironically the board are the only ones interested in buying!

The board have been selling down all year.

Tesla sell off Maxwell tech while in litigation with CAP-XX. Does anyone think Musk has tried to scupper CAP-XX's financial success with this deal, at this point in time? What if CAP-xx win, but there is no money in the new company arrangement to pay CAP-xx, and no desire to become a licencee?

Are the board aware of this scenario and sold down accordingly?

Thanks for providing the update, DerSack.

If GM is depressing the price with these huge sales, it'll definitely be worth keeping an eye on it, to time the bottom.

Kestrel added again today. 15,000 shares at full market price, bringing their holding up to 28.05% of the company.

Clearly they see a decent rise in the share price from here otherwise they wouldn't continue to sink in so much money.

Non-exec director Mr Scott, who is a partner at Kestrel, must have inside knowledge that this is a business on the up and up, and is willing for Kestrel to continue to invest at these prices.

Kestrel are still buying, they must be very confident in ULS. The more the price slides the more they are loading up.

I understand the anger, but the CEO doesn't have anything to do with the product itself. Oxilio, or any other Pharma, would conduct their own testing to determine whether NFX has anything worthwhile, and make their decision based on that data.

Today's RNS is not a good look for the company, but doesn't affect the product at all.

There could also be news on NXP001, NXP003, NXP004 and a new work-in-progress NXP005 in the next 6 months.... but it ain't gonna happen.

Dr Anne was a great coup for the company to hire her, but she has clearly seen how small the NFX prospects are and how long it will take, and jumped ship for a better offer elsewhere.

I don't blame her, but I am (again) incredibly disappointed in my investment.

TWatcher is very active on ADVFN boards, sowing the same FUD and negativity.

A sad individual.

DP sounds ****ed off at having to deal with the amateurs involved in the project.

The RNS, which is reassuring btw, basically says, "We'll do your job for you. But we're taking control of it."

Current BOOM mcap = £140m (or $200m)

With revenue being equal between Wondery and Audioboom ($40m), and ceteris paribus, if Wondery sold for $300m, and assuming Audioboom could be sold for an equivalent amount, that puts a BOOM takeover at a 50% rise to today's share price, so 1350p per share.

It's 46.9p to buy £3k worth of shares right now.

MMs short of stock!

I share the frustration. AIM shares will slide during periods of no news, but the biggest elephant in the room is the funding required to fund the Poland plant.

The continued silence from the company suggests a fundraise is coming.

Could today be the day that finally stops the 2 month down trend?

Surely there can't be anyone left who wants to sell EQT or they would have done so by now?

Also, having a greater number of shares increases the liquidity of the company for trading, which is a good thing.

If a share is illiquid, then it can be difficult to buy and sell when you want, in the qauntities you want. The buy/sell spread will likely be higher too. Look at the problems Neil Woodford ran into when trying to offload illiquid holdings from his fund when he got rumbled a couple of years ago.

All 3 of those companies are very liquid, so I don't care whether there are 1bn, 4bn, or 8bn shares in circulation. As Abdalian and Agricore said, mcap and EPS are things to consider, not amount of shares.

Pleased with results today. If the market focuses superficially on H1 revenue of $1m, the share price might drop, but this represents a little bonus for anyone wishing to increase their stake in what is becoming a diversified and rapidly expanding world-class proposition.